iatroX logo
brainstormaskiatroXquizcpdknowledge centrehow it worksaboutblog
Knowledge Centre / Gallbladder Cancer

Gallbladder Cancer

Diagnosis and management of gallbladder malignancy.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 30 August 2025
OncologySurgeryHepatology

Clinical Guidelines

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
National
Clinical Practice Guideline on Cholangiocarcinoma and Gallbladder Cancer (Alberta Health Services)
National
Gallbladder Cancer Treatment (PDQ®) – Health Professional Version (NCI)
National
IHPBA-APHPBA clinical practice guidelines: international Delphi consensus recommendations for gallbladder cancer
National
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Gallbladder Cancer
National

Recent iatroX Q&As

  • What are the key clinical features that may suggest gallbladder cancer in a patient presenting with biliary symptoms?Updated: 8/22/2025
  • Which imaging modalities are recommended for the initial evaluation of suspected gallbladder malignancy in primary care?Updated: 8/22/2025
  • What are the referral criteria for a patient with suspected gallbladder cancer to a specialist for further investigation?Updated: 8/22/2025
  • How should I approach the management of a patient diagnosed with early-stage gallbladder cancer in primary care?Updated: 8/22/2025
  • What follow-up protocols should be implemented for patients treated for gallbladder cancer to monitor for recurrence?Updated: 8/22/2025
ask iatroX
privacy terms faq
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play